GSDMD and amyotrophic lateral sclerosis: Observations of ALS patients and TDP-43 and SOD1 mutant mice showed NLRP3 activation, increases in IL-18, and cleavages of GSDMD in microglial cells distributed in the spinal cord and motor cortex of the brain [49,50,51].